Mesoblast | MSB - Spese Operative





Spese Operative Cambiamento Data
Avita Medical AUD 28.02M 1.55M 2025-12
Clinuvel Pharmaceuticals AUD 23.42M 6.49M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Pacific Edge NZD 22.5M 2.84M 2026-06
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Ramsay Health Care AUD 8.8B 83.5M 2025-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Starpharma Holdings AUD 11.7M 7.69M 2025-12
Telix Pharmaceuticals AUD 430.99M 25.59M 2026-06